Point-of-Care Isn’t a Marketing Tactic—It’s a Gross-to-Net Strategy

Key Takeaways

• Point‑of‑care messaging drives higher first‑fill rates
• EHR channels enable prescriber‑level ROI measurement
• Strategic point‑of‑care links copay programs to prescriptions
• Data‑driven tactics improve therapy continuity within quarters
• Brands treating point‑of‑care as lever outperform peers

Summary

Point‑of‑care (PoC) messaging has shifted from a peripheral marketing tactic to a core gross‑to‑net lever for pharmaceutical brands. By delivering timely, relevant information at prescribing or dispensing moments, PoC improves first‑fill rates and therapy continuity. The rise of electronic health‑record (EHR) channels enables prescriber‑level measurement, allowing brands to link access investments—such as copay assistance—to actual prescription outcomes. Companies that embed PoC strategically outperform peers on both acquisition and retention metrics.

Pulse Analysis

The pharmaceutical landscape is increasingly data‑centric, and point‑of‑care (PoC) has emerged as a pivotal activation layer that translates access investments into measurable revenue. Unlike traditional brand awareness campaigns, PoC delivers concise, evidence‑based messages at the exact moment a clinician writes a prescription or a pharmacist dispenses medication. This immediacy not only educates providers and patients but also aligns with gross‑to‑net objectives by nudging patients toward first fills and sustained therapy, a critical factor as drug pricing scrutiny intensifies.

A key catalyst for PoC’s ascent is the proliferation of electronic health‑record (EHR) integrations, which grant marketers unprecedented prescriber‑level visibility. Through test‑and‑control methodologies, brands can attribute each dollar spent to specific physicians, generating ROI insights within a single quarter. This granular feedback loop enables rapid optimization—adjusting creative, timing, or channel mix—to maximize impact while minimizing waste. Moreover, the ability to capture real‑time data supports predictive modeling, allowing firms to forecast fill rates and allocate resources more efficiently.

When PoC is woven into the broader patient support ecosystem—such as copay assistance, adherence programs, and specialty pharmacy services—it creates a seamless experience that reinforces the value proposition at every touchpoint. The result is a measurable lift in first‑fill conversion and a reduction in therapy gaps, directly enhancing gross‑to‑net performance. For pharma executives, embracing PoC as a strategic, data‑driven lever is no longer optional; it is a competitive necessity to safeguard revenue in an increasingly outcome‑focused market.